Selective arterial embolization for control of bleeding in gynecologic malignancy

Mann, William J.; Jander, H. Peter; Partridge, Edward E.; Russinovich, N A; Hatch, Kenneth D.; Taylor, Peyton T.; Shingleton, Hugh M.

doi:10.1016/0090-8258(80)90095-5

Cited by 5 publications

(3 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additional smaller series have similarly shown high success rates. 10,[67][68][69] Angiography may not always reveal a discrete site of bleeding, in which case empiric embolization can be performed similar to the paradigm of pelvic trauma. Given the vast array of contemporary endovascular tools, selective catheterization of the anterior division of the internal iliac artery should be feasible in almost every patient.…”

Section: Gynecologic Malignanciesmentioning

confidence: 99%

“…Both selective (i.e., anterior division of internal iliac artery) and superselective embolization can be helpful for these patients. 68 Unlike patients with benign uterine leiomyomas undergoing uterine fibroid embolization, the relevant arteries in patients with chronic malignant bleeding may not demonstrate substantial hypertrophy. Moreover, prior radiation therapy can cause vascular sclerosis, degrading the arterial supply into a spider's web of tiny nourishing branches.…”

Section: Gynecologic Malignanciesmentioning

confidence: 99%

See 1 more Smart Citation

Palliative Embolization for Refractory Bleeding

Niekamp

Sheth

Kuban

et al. 2017

Semin intervent Radiol

View full text Add to dashboard Cite

Bleeding is a common and often challenging complication of malignancy. Etiologies of hemorrhage in this patient population vary, and bleeding may present as an acute, life-threatening emergency or a chronic, low-volume blood loss. For patients with advanced malignancies, interventions to manage bleeding must be balanced by the patient's life expectancy and quality of life. As such, minimally invasive procedures such as transarterial embolization are useful therapeutic options in appropriately selected patients. There is a rich history of palliative transarterial embolization for refractory bleeding in cancer patients. This technique was first applied in the 1970s and has since become an established treatment tool for malignancy-related bleeding throughout the body. While the preponderance of published data comprised case reports and small retrospective studies, the use of embolization continues to expand as experience grows and techniques are refined. In this review, we summarize the literature and provide our perspective on embolization for refractory bleeding in cancer patients.

show abstract

Section: Gynecologic Malignanciesmentioning

confidence: 99%

Section: Gynecologic Malignanciesmentioning

confidence: 99%

Palliative Embolization for Refractory Bleeding

Niekamp

Sheth

Kuban

et al. 2017

Semin intervent Radiol

View full text Add to dashboard Cite

show abstract

“…In embolization procedures performed in the 20th century, the most common embolic agents were made of autologous blood clot, muscle fragments or even stainless steel pellets [11]. Other applications of vascular embolization include treatment of arteriovenous fistula [49], pulmonary hemorrhage [50], hemorrhage related to other medical procedures [51,52,53] and, more recently, tumors [54,55,56].…”

Section: History and Applicationsmentioning

confidence: 99%